The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Malaria causes significant mortality and morbidity in sub-Saharan Africa (SSA), especially among children less than five years of age (U5 children). Although the economic burden of malaria in this region has been assessed previously, the extent and variation of this burden remains unclear. This study aimed to estimate the economic costs of malaria in U5 children in three countries (Ghana, Tanzania and Kenya). Methods: Health system and household costs previously estimated were integrated with costs associated with co-morbidities, complications and productivity losses due to death. Several models were developed to estimate the expected treatment cost per episode per child, across different age groups, by level of severity and with or without controlling for treatment-seeking behaviour. Total annual costs (2009) were calculated by multiplying the treatment cost per episode according to severity by the number of episodes. Annual health system prevention costs were added to this estimate. Results: Household and health system costs per malaria episode ranged from approximately US$ 5 for non-complicated malaria in Tanzania to US$ 288 for cerebral malaria with neurological sequelae in Kenya. On average, up to 55% of these costs in Ghana and Tanzania and 70% in Kenya were assumed by the household, and of these costs 46% in Ghana and 85% in Tanzania and Kenya were indirect costs. Expected values of potential future earnings (in thousands) lost due to premature death of children aged 0–1 and 1–4 years were US$ 11.8 and US$ 13.8 in Ghana, US$ 6.9 and US$ 8.1 in Tanzania, and US$ 7.6 and US$ 8.9 in Kenya, respectively. The expected treatment costs per episode per child ranged from a minimum of US$ 1.29 for children aged 2–11 months in Tanzania to a maximum of US$ 22.9 for children aged 0–24 months in Kenya. The total annual costs (in millions) were estimated at US$ 37.8, US$ 131.9 and US$ 109.0 nationwide in Ghana, Tanzania and Kenya and included average treatment costs per case of US$ 11.99, US$ 6.79 and US$ 20.54, respectively. Conclusion: This study provides important insight into the economic burden of malaria in SSA that may assist policy makers when designing future malaria control interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Murphy, S., & Breman, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.57 · Cited by 451
Iron deficiency and malaria among children living on the coast of Kenya
Nyakeriga, A. M., Troye‐Blomberg, M., Dorfman, J. R., Alexander, N. D., Bäck, R., Kortok, M., Chemtai, A. K., Marsh, K., & Williams, T. N. (2004) · The Journal of Infectious Diseases · doi:10.1086/422331 · Cited by 168 · cited 1×
“Fifth, although costs associated with severe anemia were estimated and used in the models, as a conservative measure, they were not included in the aggregate annual costs of malaria due to the complex and unclear interaction between malaria and anemia [66].”
Method
Cited by
Emerging roles for platelets as immune and inflammatory cells
Morrell, C. N., Aggrey, A. A., Chapman, L. M., & Modjeski, K. L. (2014) · Blood · doi:10.1182/blood-2013-11-462432 · Cited by 735
Malaria medicines: a glass half full?
Wells, T. N. C., van Huijsduijnen, R. H., & Van Voorhis, W. C. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4573 · Cited by 430
Sterile Insect Technique: Principles and Practice in Area-Wide Integrated Pest Management
Dyck, V. A., Hendrichs, J., & Robinson, A. S. (2021) · CRC Press eBooks · doi:10.1201/9781003035572 · Cited by 371
Changes in Malaria Epidemiology in Africa and New Challenges for Elimination
Nkumama, I. N., O’Meara, W. P., & Osier, F. H. A. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2016.11.006 · Cited by 286
Assessing Climate Driven Malaria Variability in Ghana Using a Regional Scale Dynamical Model
Asare, E., & Amekudzi, L. (2017) · Climate · doi:10.3390/cli5010020 · Cited by 35
“[5] estimated that about 55% of the total cost of malaria treatment in 2009, which ranged between US$ 7.”
BackgroundSpatial Prevalence and Determinants of Malaria among under-five Children in Ghana
Ejigu, B. A., & Wencheko, E. (2021) · doi:10.1101/2021.03.12.21253436 · Cited by 17
Pregnancy-associated Malaria, Challenges and Prospects in Sub-Saharan Africa
Aguzie, I. O. N. (2018) · Clinics in Mother and Child Health · doi:10.4172/2090-7214.1000282 · Cited by 13
Metadata
- Authors
- Sicuri, E., Vieta, A., Lindner, L., Constenla, D., & Sauboin, C.
- Venue
- Malaria Journal
- Published
- 2013-09-03
- Volume
- 12
- Issue
- 1
- Pages
- 307-307
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2139303310
- Cited by
- 109
- References
- 3
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.